19079-Solid Tumors-NA-564

Solid Tumors

(INCB 54828-207) A Phase 2, Open-Label, Single-Arm, Multicenter Study to Evaluate the Efficacy and Safety of Pemigatinib in Participants With Previously Treated Locally Advanced/Metastatic or Surgically Unresectable Solid Tumor Malignancies Harboring Activating FGFR Mutations or Translocations (FIGHT-207)

  • Details

ClinicalTrials.gov ID: NCT03822117
Diagnosis Type: NA
USOR Number:

  • Address

8820 Huron St
Thornton, CO 80260
P: (303) 386-7622

Search by practice name, trial titles, indicators and specific disease types.